Skip to main content

Advertisement

SpringerLink
Log in

Proteinuria in a patient with Graves’ disease: Questions

  • Clinical Quiz
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the international study of kidney disease in children. Lancet 760:1299–1302

    Article  CAS  PubMed  Google Scholar 

  2. International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165

    Article  Google Scholar 

  3. Cameron JS (1990) Membranous nephropathy in childhood and its treatment. Pediatr Nephrol 4:193–198

    Article  CAS  PubMed  Google Scholar 

  4. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travel and new roads ahead. Kidney Int 77:765–770

    Article  CAS  PubMed  Google Scholar 

  6. Cossey LN, Walker PD, Chris PL (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28:2307–2311

    Article  PubMed  Google Scholar 

  7. Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V (2015) Antibodies to M-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Nephrology 20:572–575

    Article  CAS  PubMed  Google Scholar 

  8. O’Regan, Fong JSC, Kaplan BS, De Chadarevian JP, Lapointe N, Drummond KN (1976) Thyroid antigen -antibody nephritis. Clin Immunol Immunopathol 6:341–346

    Article  PubMed  Google Scholar 

  9. Jordan SC, Buckingham B, Sakai R, Olson D (1981) Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 304:1212–1215

    Article  CAS  PubMed  Google Scholar 

  10. Horvath F Jr, Teague P, Gaffney EF, Mars DR, Fuller TJ (1979) Thyroid antigen associated immune complex glomerulonephritis in Graves’ disease. Am J Med 67:901–904

    Article  PubMed  Google Scholar 

  11. Ploth DW, Fitz A, Schnetzler D, Seidenfeld J, Wilson CB (1978) Thyroglobulin-anti- thyroglobulin immune complex glomerulonephritis complicating radioiodine therapy. Clin Immunol Immunopathol 9:327–334

    Article  CAS  PubMed  Google Scholar 

  12. Sato Y, Sasaki M, Kan R, Osaku A, Koyama S, Shibayama S, Sato M, Narumiya K, Takagi T, Kojima M (1989) Thyroid antigen-mediated glomerulonephritis in Graves’ disease. Clin Nephrol 31:49–52

  13. Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, Nozu K, Iijima K, Yoshikawa N (2009) Membranous nephropathy associated with thyroid peroxidase antigen. Pediatr Nephrol 24:605–608

  14. Sasaki K, Yasuda K, Nakanishi K, Rakugi H, Isaka Y, Yamato M (2014) Membranous nephropathy secondary to Graves’ disease with deposits of thyroid peroxidase in an adult. CEN Case Rep 3:90–93

    Article  PubMed  Google Scholar 

  15. Keenswijk W, Degraeuwe E, Hoorens A, Dorpe JV, Vande Walle J (2018) A case of Graves’ disease associated with membranoproliferative glomerulonephritis and leukocytoclastic vasculitis. J Pediatr Endocrinol Metab 31(10):1165–1168

    Article  PubMed  Google Scholar 

  16. Shimamura Y, Tsushima T, Moniwa N, Hasegawa K, Ogawa Y, Takizawa H (2014) Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves’ disease: a case report. J Med Case Rep 8:305

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hasnain W, Stillman IE, Bayliss GP (2011) Minimal- change renal disease and Graves’ disease: a case report and literature review. NDT Plus 4:96–98

    PubMed  PubMed Central  Google Scholar 

  18. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A (1994) Antineutrophil cystoplasmic autoantibody–positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr 124:986–988

    Article  CAS  PubMed  Google Scholar 

  19. D’Cruz D, Chesser AM, Lightowler C, Comer M, Hurst MJ, Baker LR, Raine AE (1995) Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. Br J Rheumatol 34:1090–1091

    Article  PubMed  Google Scholar 

  20. Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A (1996) Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron 74:734–735

    Article  CAS  PubMed  Google Scholar 

  21. Lionaki S, Vlachopanos G, Georgalis A, Ziakas P, Gakiopoulou H, Petra C, Boletis J (2013) Lupus nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole. Lupus 22:95–98

    Article  CAS  PubMed  Google Scholar 

  22. Wang LC, Tsai WY, Yang YH, Chiang BL (2003) Methimazole-induced lupus erythematosus: a case report. J Microbiol Immunol Infect 36:278–281

    PubMed  Google Scholar 

  23. Reynolds LR, Bhathena D (1979) Nephrotic syndrome associated with methimazole therapy. Arch Intern Med 139:236–237

    Article  CAS  PubMed  Google Scholar 

  24. Ayalon R, Beck LH (2015) Membranous nephropathy: not just a disease for adults. Pediatr Nephrol 30:31–39

    Article  PubMed  Google Scholar 

  25. Kidney Disease Improving global outcomes (KDIGO) glomerulonephritis work group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274

    Article  Google Scholar 

  26. McQuarrie EP, Stirling CM, Geddes CC (2012) Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence –based therapy. Nephrol Dial Transplant 27:235–242

    Article  CAS  PubMed  Google Scholar 

  27. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923–924

    Article  CAS  PubMed  Google Scholar 

  28. Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M, Perna A, Filippi C, Remuzzi G (2003) Rituximab in idiopathic membranous nephropathy: a one year prospective study. J Am Soc Nephrol 14:1851–1857

  29. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC (2010) Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 5:2188–2198

  30. Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A,  Marasà M,  Remuzzi G (2012) Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1416–1425

  31. Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859–866

    Article  CAS  PubMed  Google Scholar 

  32. Weigle WO, Nakamura RK (1969) Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin. Clin Exp Immunol 4:645–657

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A,  Baltar J, Fresnedo GF, Martín C, Pons S,  Lorenzo D,  Bernis C, Arrizabalaga P, Juárez GF, Barrio V,  Sierra M, Castellanos I, Espinosa M, Rivera F, Oliet A,Vega FF, Praga M(2010) Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21:697–704

  34. De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC (2017) A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol 28:421–430

    Article  PubMed  Google Scholar 

  35. Fervenza FC, Sethi S, Specks U (2008) Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3:905–919

    Article  PubMed  Google Scholar 

  36. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group (2004) Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int 66:1199–1205

    Article  PubMed  Google Scholar 

  37. Bomback AS, Fervenza FC (2018) Membranous nephropathy: approaches to treatment. Am J Nephrol 47:30–42

    Article  CAS  PubMed  Google Scholar 

  38. Malatesta- Muncher R, Eldin KW, Beck LH Jr, Michael M (2018) Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol 33:1089–1092

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Endocrinology, Cerrahpasa Faculty of Medicine, Istanbul University- Cerrahpasa, 34098, Fatih, Istanbul, Turkey

    Aydilek Dagdeviren Cakir, Hande Turan, Oya Ercan & Olcay Evliyaoglu

  2. Department of Pediatric Nephrology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey

    Nur Canpolat & Seha Saygili

  3. Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Isin Kilicaslan

Authors
  1. Aydilek Dagdeviren Cakir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nur Canpolat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seha Saygili
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Isin Kilicaslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hande Turan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Oya Ercan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Olcay Evliyaoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aydilek Dagdeviren Cakir.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The answers to these questions can be found at https://doi.org/10.1007/s00467-019-04221-x.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dagdeviren Cakir, A., Canpolat, N., Saygili, S. et al. Proteinuria in a patient with Graves’ disease: Questions. Pediatr Nephrol 34, 1379–1381 (2019). https://doi.org/10.1007/s00467-019-04220-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-019-04220-y

Keywords

Search

Navigation